Company Medovex Corp Nasdaq
Equities
US58504H1014
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 08/19/08 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 04/19/04 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 15/20/15 |
William E. Horne
BRD | Director/Board Member | 70 | 09/18/09 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 17/22/17 | |
Chief Executive Officer | 53 | 08/19/08 | |
William E. Horne
BRD | Director/Board Member | 70 | 09/18/09 |
Chairman | 77 | 08/19/08 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 17/22/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 712,710 | 253,876 ( 35.62 %) | 0 | 35.62 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+12.85% | 23TCr | |
+13.88% | 20TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.56% | 6.49TCr | |
+18.24% | 5.43TCr | |
+7.04% | 5.21TCr | |
+10.83% | 4.52TCr | |
+5.94% | 3.74TCr |